Cipla collaboration brings a second brand of tirzepatide, Yurpeak, to India, aiming to widen patient access for diabetes and ...

Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...

Eli Lilly and Walmart have partnered to offer in-store pickup of Zepbound (tirzepatide) single-dose vials through the LillyDirect platform by mid-November. The collaboration marks the first time ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting ...

The Zepbound vials will be offered for pick-up at Walmart pharmacies across the U.S. starting in mid-November at LillyDirect's direct-to-consumer pricing which offers the drug at half the price ...

Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...

Through its LillyDirect pharmacy, Eli Lilly plans to offer steep discounts on single-dose vials of Zepbound by partnering ...

Macquarie maintains an outperform rating on Hindustan Unilever, anticipating sales growth above 4% driven by demand recovery ...

An April 2025 report from the Initiative for Medicines, Access & Knowledge (I-MAK) presents grossly misleading information ...

India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being ...